The impact of inflammation on bone mass in children

Pediatric Nephrology

Volumn 26, Issue 11, 2011, Pages 1937-1946

  Cheung, Wai W ^a   Zhan, Jian Ying ^b   Paik, Kyung Hoon ^c   Mak, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bone mass regulation; End stage renal disease; Inflammation; Osteodystrophy. Chronic kidney disease

Indexed keywords

CALCIUM; CANNABINOID 1 RECEPTOR; COLLAGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; LEPTIN; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEONECTIN; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

BONE; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CACHEXIA; CELL ACTIVITY; CHILD; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; ENTERITIS; HUMAN; HYPERPARATHYROIDISM; IMMOBILIZATION; IMMUNE DEFICIENCY; INFLAMMATION; METABOLIC ACIDOSIS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY;

BONE AND BONES; BONE REMODELING; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION;

EID: 83155184764     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-010-1733-5     Document Type: Review

References (115)

1. Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309-320
2. Herman S, Kronke G, Schett G (2008) Molecular mechanisms of inflammatory bone damage, emerging targets for therapy. Trends Mole Medicine 14:245-253
3. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
4. Schett G (2007) Joint remodeling in inflammatory disease. Ann Rheum Dis 66(S3):iii42-iii44
5. Sims NA, Gooi JH (2008) Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Seminars Cell Develop Biol 19:444-451
6. Teotelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508
7. Seeman E (2009) Bone modeling and remodeling. Crit Rev Eukaryot Gene Expr 19:219-233
8. Parfitt AM (1982) The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res 4:1-6
9. Leonard MB (2003) Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques. Med Pediatr Oncol 41(3):198-207 (Pubitemid 36910128)
10. LeonardMB (2007) Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 119(S2):S166-S174 (Pubitemid 46397939)
11. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 73(3):555-563 (Pubitemid 21921908)
12. Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R (1994) Peak bone mass. Osteoporos Int 4(Suppl 1):7-13
13. Rouster-Stevens KA, Klein-Gitelman MS (2005) Bone health in pediatric rheumatic disease. Curr Opin Pediatr 17(6):703-708 (Pubitemid 41689661)
14. Matsuo K, Irie N (2008) Osteoclast-osteoblast communication. Arch Biochem Biophysis 473:201-209
15. Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H (2004) Osteoclast differentiation by RANKL requires NF-kappaBmediated downregulation of cyclin-dependent kinase 6 (Cdk6). J Bone Miner Res 19(7):1128-1136 (Pubitemid 41110565)
16. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49-60 (Pubitemid 40207966)
17. Polzer K, Diarra D, Zwerina J, Schett G (2008) Inflammation and destruction of the joints-the Wnt pathway. Joint Bone Spine 75:105-107
18. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, RichardsWG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156-163
19. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML, Osteoporosis-Pseudoglioma Syndrome Collaborative Group (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523 (Pubitemid 33152786)
20. Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB (2006) Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 65(8):1074-1079 (Pubitemid 44133272)
21. Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25(4):711-724
22. Mak RH, Cheung W (2007) Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 16(1):27-31 (Pubitemid 44885738)
23. Strassburg S, Anker SD (2006) Metabolic and immunologic derangements in cardiac cachexia: where to from here? Heart Fail Rev 11(1):57-64 (Pubitemid 43986208)
24. Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21 (2):195-214
25. Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, Marumo K (2010) Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone 46(4):1170-1179
26. Doorenbos CR, van den Born J, Navis G, de Borst MH (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5 (12):691-700
27. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116 (12):3150-3159 (Pubitemid 44878629)
28. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281
29. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG, Iowa Women's Health Study (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72-77 (Pubitemid 38084289)
30. Rauch F, Schoenau E (2001) The developing bone: slave or master of its cells and molecules? Pediatr Res 50:309-314 (Pubitemid 32801953)
31. Frost HM, Schönau E (2000) The "muscle-bone unit" in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab 13:571-590 (Pubitemid 30435928)
32. Krøllner B, Toft B, Pors Nielsen S, Tøndevold E (1983) Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin Sci 64:541-546 (Pubitemid 13164496)
33. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488 (Pubitemid 32038586)
34. Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, van den Berg W, Schett G (2007) TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 104:11742-11747 (Pubitemid 47175083)
35. Canaff L, Zhou X, Hendy GN (2008) The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. Biol Chem 283 (20):13586-13600
36. Canaff L, Hendy GN (2005) Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements. J Biol Chem 280(14):14177-14188 (Pubitemid 40517320)
37. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD (1996) Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774-1783 (Pubitemid 26367689)
38. Reid IR (1998) Glucocorticoid effects on bone. J Clin Endocrinol Metab 83:1860-1862 (Pubitemid 28496306)
39. Wong MM, Rao LG, Ly H, Hamilton L, Tong J, Sturtridge W, McBroom R, Aubin JE, Murray TM (1990) Long-term effects of physiologic concentrations of dexamethasone on human bonederived cells. J Bone Miner Res 5:803-813 (Pubitemid 20294764)
40. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282 (Pubitemid 28335186)
41. Seene T (1994) Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy. J Steroid Biochem Mol Biol 50:1-4 (Pubitemid 24230488)
42. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868-875 (Pubitemid 39096913)
43. Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 24 (3):503-513
44. Walsh NC, Crotti TN, Goldring SR, Gravallese EM (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208:228-251 (Pubitemid 41746396)
45. Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteoporosis, inflammation and ageing. Immun Ageing 2:14
46. Campisi G, Chiappelli M, De Martinis M, Franco V, Ginaldi L, Guiglia R, Licastro F, Lio D (2009) Pathophysiology of agerelated diseases. Immun Ageing 6:12
47. van den Berg WB (2009) Lessons from animal models of arthritis over the past decade. Arthritis Res Ther 11(5):250
48. Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, Hsu PN (2008) TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. Mol Immunol 45(8):2205-2213
49. Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB (2008) Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits. Arthritis Rheum 58(8):2518-2527
50. Fournier C (2005) Where do T cells stand in rheumatoid arthritis? Joint Bon Spine 72:527-532 (Pubitemid 41821411)
51. Viswanathan A, Sylvester FA (2008) Chronic pediatric inflammatory disease: effects on bone. Rev EndocrMetab Disord 9:107-122
52. McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27:17-23 (Pubitemid 43083560)
53. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345-1352 (Pubitemid 29218305)
54. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582-588 (Pubitemid 39572108)
55. Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM, Hewison M (1999) Characterization of 11betahydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J Endocrinol 161:455-464 (Pubitemid 29278801)
56. Eyre LJ, Rabbitt EH, Bland R, Hughes SV, Cooper MS, Sheppard MC, Stewart PM, Hewison M (2001) Expression of 11β-hydroxysteroid dehydrogenase in rat osteoblastic cells: prereceptor regulation of glucocorticoid responses in bone. J Cell Biochem 81:453-462 (Pubitemid 32405763)
57. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M,Stewart PM (2000) Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 27:375-381 (Pubitemid 30658120)
58. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM (2001) Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037-1044 (Pubitemid 32467147)
59. Bowyer S, Roettcher P (1996) Pediatric rheumatology clinic populations in the United States: results of a 3-year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 23:1968-1974 (Pubitemid 26376126)
60. Burnham JM, Shults J, Petit MA, Semeao E, Beck TJ, Zemel BS, Leonard MB (2007) Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease. J Bone Miner Res 22(4):551-559 (Pubitemid 47457432)
61. Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, Leonard MB (2005) Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 82(2):413-420
62. Khadgawat R, Makharia GK, Puri K (2008) Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol 27 (3):103-106
63. Smith J, Lidofsky S (2009) Bone disease in the inflammatory bowel disease population. Med Health R I 92(4):125-127
64. Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 136(1):123-130
65. Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN, Reach Study Group (2008) Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol 6(12):1378-1384
66. Tuchman S, Thayu M, Shults J, Zemel BS, Burnham JM, Leonard MB (2008) Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr 153(4):484-490
67. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM (1998) Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 42:188-194 (Pubitemid 28214002)
68. Silvennoinen J (1996) Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 239:131-137 (Pubitemid 26043148)
69. Varghese S, Wyzga N, Griffiths AM, Sylvester FA (2002) Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35:641-648 (Pubitemid 35417735)
70. Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB (2007) Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis 13(9):1121-1128 (Pubitemid 47402596)
71. Sylvester FA, Davis PM, Wyzga N, Hyams JS, Lerer T (2006) Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr 148(4):461-466
72. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. JClin Endocrinol Metab 92(2):443-449
73. Weaver CM, Peacock M, Martin BR, McCabe GP, Zhao J, Smith DL, Wastney ME (1979) Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. J Bone Miner Res 12 (10):1714-1720
74. Blumsohn A, Hannon RA, Wrate R, Barton J, al-Dehaimi AW, Colwell A, Eastell R (1994) Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 40(5):663-670 (Pubitemid 24194671)
75. Rotteveel J, Schoute E, Delemarre-van de Waal HA (1997) Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels. Acta Paediatr 86(2):143-147 (Pubitemid 27086764)
76. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, YamauchiS, Tanaka H, Seino Y (1997) Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 82 (7):2056-2061 (Pubitemid 27287561)
77. Hardy RS, Filer A, Cooper MS, Parsonage G, Raza K, Hardie DL, Rabbitt EH, Stewart PM, Buckley CD, Hewison M (2006) Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Res Ther 8:R108
78. Bryndová J, Zbánková S, Kment M, Pácha J (2004) Colitis upregulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand J Gastroenterol 39:549-553 (Pubitemid 38916260)
79. Stegk JP, Ebert B, Martin HJ, Maser E (2009) Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol 301:104-108
80. Czock D, Keller F, Rasche FM, Häussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44(1):61-98 (Pubitemid 40096038)
81. Taal MW, Masud T, Green D, Cassidy MJ (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Tranplant 14:1922-1928 (Pubitemid 29358889)
82. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293 (Pubitemid 29072230)
83. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global Outcomes (KDIGO) (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953 (Pubitemid 43924257)
84. Klaus G, Watson A, Edefonti A, Fischbach M, Rönnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schröder C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151-159 (Pubitemid 43115864)
85. Wong H, Mylrea K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585-590 (Pubitemid 44141587)
86. Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R (1998) Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 12:328-337 (Pubitemid 28254474)
87. Salusky IB, Kuizon BG, Jüppner H (2004) Special aspects of renal osteodystrophy in children. Semin Nephrol 24:69-77 (Pubitemid 38141847)
88. Sanchez CP, Kuizon BD, Abdella PA, Jüppner H, Salusky IB, Goodman WG (2000) Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536-1544 (Pubitemid 32269123)
89. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349 (Pubitemid 26076383)
90. Carrero JJ, Ortiz A, Qureshi AR, Martín-Ventura JL, Bárány P, Heimbürger O, Marrón B, Metry G, Snaedal S, Lindholm B, Egido J, Stenvinkel P, Blanco-Colio LM (2009) Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. Clin J Am Soc Nephrol 4:110-118
91. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M (2005) IL- 10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67:1216-1233 (Pubitemid 40463099)
92. Stenvinkel P, Pecoits-Filho R, Lindholm B, for the DialGene Consortium (2005) Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 18:322-330 (Pubitemid 41159583)
93. Eleftheriadis T, Kartsios C, Antoniadi G, Kazila P, Dimitriadou M, Sotiriadou E, Koltsida M, Golfinopoulos S, Liakopoulos V, Christopoulou- Apostolaki M (2008) The impact of chronic inflammation on bone turnover in hemodialysis patients. Ren Fail 30:431-437 (Pubitemid 351868698)
94. Türk S, Akbulut M, Yildiz A, Gürbilek M, Gönen S, Tombul Z, Yeksan M (2002) Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron 90:188-194 (Pubitemid 34701995)
95. Montalbán C, García-Unzueta MT, De Francisco AL, Amado JA (1999) Serum interleukin-6 in renal osteodystropgy: relationship with serum PTH and bone remodeling markers. Horm Metab Res 31:14-17 (Pubitemid 29081246)
96. Steddon SJ, McIntyre CW, Schroeder NJ, Burrin JM, Cunningham J (2004) Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu. Nephrol Dial Transplant 19:3078-3083 (Pubitemid 40057631)
97. Sánchez MC, Bajo MA, Selgas R, Mate A, Sánchez-Cabezudo MJ, López-Barea F, Esbrit P, Martínez ME (2001) Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in vitro selection of interleukin-6 and osteoblastic cell makers. Am J Kidney Dis 37:30-37 (Pubitemid 32055015)
98. Duarte ME, Carvalho EF, Cruz EA, Lucena SB, Andress DL (2002) Cytokine accumulation in osteitis fibrosa of renal osteodystrophy. Braz J Med Biol Res 35:25-29 (Pubitemid 34183198)
99. Langub MC Jr, Koszewski NJ, Turner HV, Monier-Faugere MC, Geng Z, Malluche HH (1996) Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy. Kidney Int 50:515-520 (Pubitemid 26274379)
100. Karsenty G (2006) Convergence between bone and energy homeostasis: leptin regulation of bone mass. Cell Metab 4:341-348 (Pubitemid 44645074)
101. Lieben L, Callewaert F, Bouillon R (2009) Bone and metabolism: a complex crosstalk. Horm Res 71(S1):134-138
102. Baek K, Bloomfield SA (2009) Beta-adrenergic blockade and leptin replacement effectively mitigate disuse bone loss. J Bone Miner Res 24:792-799
103. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207 (Pubitemid 30064908)
104. Cumin F, Baum HP, Levens N (1996) Leptin is cleared from the circulation primarily by the kidney. Int J Obes Relat Metab Disord 20:112-126
105. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, Kurnik PB, O'Connor J, Sinha M, Caro JF (1997) Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980-1985 (Pubitemid 27252771)
106. Daschner M, Tönshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, Wühl E, Rascher W, Mehls O (1998) Inappropriate elevate of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9:1074-1079 (Pubitemid 28264735)
107. Brown SA, Rosen CJ (2003) Osteoporosis. Med Clin North Am 87:1039-1063 (Pubitemid 37339021)
108. Coen G, Ballanti P, Fischer MS, Balducci A, Calabria S, Colamarco L, Di Zazzo G, Lifrieri F, Manni M, Sardella D, Nofroni I, Bonucci E (2003) Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 42:1036-1042 (Pubitemid 37322920)
109. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) Role of leptin and melanocortin signaling in uremiaassociated cachexia. J Clin Invest 115:1659-1665 (Pubitemid 40814675)
110. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279 (Pubitemid 30483131)
111. Cheung W, Vanek C, Iwaniec UT, Turner RT, Klein RF, Mak RH (2007) A novel hypothalamic mechanism in uremic bone disease. Abstract, 39th Annual Meeting American Society of Nephrology, SA-FC006, November 1st-4th, San Francisco, California, USA
112. Bjurholm A, Kreicbergs A, Terenius L, Goldstein M, Schultzberg M (1988) Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. Auton Nerv Syst 25:119-125 (Pubitemid 19057144)
113. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915-921 (Pubitemid 34275112)
114. Patel MS, Elefterios F (2007) The new field of neuroskeletal biology. Calf Tissue Int 80:337-347 (Pubitemid 46897447)
115. Adu-Zikri N, El-Fattah AA, Raafat M, Ismail L, Yahya A, Ahmed A, El-Sadek SA, El-Shamaa A, El-Sheikh N (2009) Study of neuropeptide Y and its relation to the cardiovascular complications in end stage renal disease. World J Med Sci 4:22-32